Physician profile
Jon M Ruderman
NPI 1912000944
$3,088.58
in general payments reported to CMS, 2019-2025
19 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $321 · 2021: $491 · 2022: $375 · 2023: $538 · 2024: $746 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,446.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $501.28 | 2019-2022 | |
| Abbvie INC. | $475.56 | 2022-2025 | Durysta, Xen Glaucoma Treatment System, Lumigan |
| Novartis Pharmaceuticals Corporation | $288.73 | 2019-2023 | |
| Alcon Vision LLC | $260.99 | 2021-2024 | Rocklatan, Hydrus Microstent |
| Sun Pharmaceutical Industries INC. | $217.21 | 2019-2024 | Cequa |
| Glaukos Corporation | $215.27 | 2019-2024 | Idose |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $179.67 | 2019-2021 | |
| Sight Sciences, INC. | $143.74 | 2023-2025 | Omni Surgical System, Tearcare System, Sion Surgical Instrument |
| Aerie Pharmaceuticals, INC. | $143.19 | 2020-2021 | |
| New World Medical,INC. | $137.67 | 2019-2024 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Bausch & Lomb Americas INC. | $123.45 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $95.04 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $69.14 | 2024 | Vevye |
| Thea Pharma INC. | $56.46 | 2024 | Iyuzeh |
| Oyster Point Pharma, INC. | $55.82 | 2022-2024 | Tyrvaya |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $48.87 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $38.56 | 2023-2025 | Tecnis Iol |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Shire North American Group INC | $18.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Ruderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.